HyeRee Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
HyeRee Cho has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Pa Hong
Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea
3 shared publications - Yoojin Nam
Department of Convergence Medicine University of Ulsan College of Medicine, Asan Medical Center Seoul Korea
3 shared publications Eunji Kim
1 shared publicationHyun Kyu Cho
1 shared publication- Jaeyoon Kim
Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon 51353, Republic of Korea
1 shared publication Nak Gyeong Ko
1 shared publication
Latest Publications
Incidental Emphysema on Health Screening Chest CT Imaging and All-Cause Mortality in a Korean Cohort
- Open Access
Feasibility and Effectiveness of 3D Coil Framing in the Embolization of Pulmonary Arteriovenous Malformations and Visceral Artery Aneurysms and Pseudoaneurysms
Background and Objectives: Three-dimensional (3D) coils offer stable initial framing in intracranial aneurysm embolization, but their utility in pulmonary and visceral vascular lesions has not been well established. The objective of this study was to assess the feasibility, safety, and effectiveness of 3D coils used as the primary framing device in pulmonary and visceral embolization. Materials and Methods: This retrospective study included 13 patients with 14 lesions, comprising seven pulmonary arteriovenous malformations (PAVMs), six splenic artery aneurysms (SAAs), and one hepatic artery pseudoaneurysm (HAP), treated between 2024 and 2025. In all lesions, a 0.018-inch 3D coil was deployed as the initial framing coil, followed by further packing with additional 3D or non-3D coils. Technical success, angiographic success, and clinical outcomes were evaluated. Results: Technical success was achieved in all lesions (14/14, 100%; 95% CI, 78.5–100). Angiographic success was achieved in 13 of 14 lesions (92.9%; 95% CI, 68.5–98.7), and clinical success was achieved in 12 of 13 lesions (92.3%; 95% CI, 66.7–98.6). Post-embolization syndrome (PES) developed in five patients with SAAs and in one patient with HAP; all complications were minor and resolved with conservative management. No coil migration or major complications occurred. Conclusions: When used as the initial framing device, 3D coils were technically feasible and achieved acceptable short-term angiographic and clinical outcomes in this small, heterogeneous series; these preliminary findings require confirmation in comparative studies.
Open AccessFeasibility and Effectiveness of 3D Coil Framing in the Embolization of Pulmonary Arteriovenous Malformations and Visceral Artery Aneurysms and Pseudoaneurysms
Background and Objectives: Three-dimensional (3D) coils offer stable initial framing in intracranial aneurysm embolization, but their utility in pulmonary and visceral vascular lesions has not been well established. The objective of this study was to assess the feasibility, safety, and effectiveness of 3D coils used as the primary framing device in pulmonary and visceral embolization. Materials and Methods: This retrospective study included 13 patients with 14 lesions, comprising seven pulmonary arteriovenous malformations (PAVMs), six splenic artery aneurysms (SAAs), and one hepatic artery pseudoaneurysm (HAP), treated between 2024 and 2025. In all lesions, a 0.018-inch 3D coil was deployed as the initial framing coil, followed by further packing with additional 3D or non-3D coils. Technical success, angiographic success, and clinical outcomes were evaluated. Results: Technical success was achieved in all lesions (14/14, 100%; 95% CI, 78.5–100). Angiographic success was achieved in 13 of 14 lesions (92.9%; 95% CI, 68.5–98.7), and clinical success was achieved in 12 of 13 lesions (92.3%; 95% CI, 66.7–98.6). Post-embolization syndrome (PES) developed in five patients with SAAs and in one patient with HAP; all complications were minor and resolved with conservative management. No coil migration or major complications occurred. Conclusions: When used as the initial framing device, 3D coils were technically feasible and achieved acceptable short-term angiographic and clinical outcomes in this small, heterogeneous series; these preliminary findings require confirmation in comparative studies.
- Open Access
- 5 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1263
Endovascular Management of Iliac Hematoma Associated with May–Thurner Syndrome Using Mechanical Thrombectomy and Bare-Metal Stenting: A Case Report
Background/Objectives: May–Thurner syndrome (MTS) is a common cause of iliofemoral deep vein thrombosis (DVT). Venous bleeding associated with MTS is extremely rare and has been reported mainly as spontaneous iliac vein rupture (SIVR) with retroperitoneal or iliac hematoma. Additionally, standardized treatment strategies have not yet been established. Herein, we report a case of an iliac hematoma associated with MTS that was successfully treated with endovascular mechanical thrombectomy and bare-metal stenting. Case Presentation: A 69-year-old man presented with acute swelling and pain in the left lower extremity. Computed tomography angiography demonstrated extensive iliofemoral DVT and an iliac hematoma adjacent to the left common iliac vessels, without definite evidence of iliac vein rupture. Initial conservative management with anticoagulation therapy was selected as the patient was hemodynamically stable and showed no active bleeding. However, follow-up imaging one week later revealed persistent DVT with interval enlargement of the hematoma. Pelvic arteriography excluded an arterial bleeding source. Endovascular treatment was performed, including mechanical thrombectomy using the AngioJet system and bare-metal stent placement to restore venous outflow. Follow-up imaging revealed complete thrombus resolution, hematoma regression, and sustained stent patency. Conclusions: Iliac hematomas associated with MTS may occur without definite radiological evidence of iliac vein rupture. In selected hemodynamically stable patients, an individualized endovascular strategy focused on venous outflow restoration using the AngioJet system and bare metal stents may be a feasible treatment option.
- 5 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1263
Open AccessEndovascular Management of Iliac Hematoma Associated with May–Thurner Syndrome Using Mechanical Thrombectomy and Bare-Metal Stenting: A Case Report
Background/Objectives: May–Thurner syndrome (MTS) is a common cause of iliofemoral deep vein thrombosis (DVT). Venous bleeding associated with MTS is extremely rare and has been reported mainly as spontaneous iliac vein rupture (SIVR) with retroperitoneal or iliac hematoma. Additionally, standardized treatment strategies have not yet been established. Herein, we report a case of an iliac hematoma associated with MTS that was successfully treated with endovascular mechanical thrombectomy and bare-metal stenting. Case Presentation: A 69-year-old man presented with acute swelling and pain in the left lower extremity. Computed tomography angiography demonstrated extensive iliofemoral DVT and an iliac hematoma adjacent to the left common iliac vessels, without definite evidence of iliac vein rupture. Initial conservative management with anticoagulation therapy was selected as the patient was hemodynamically stable and showed no active bleeding. However, follow-up imaging one week later revealed persistent DVT with interval enlargement of the hematoma. Pelvic arteriography excluded an arterial bleeding source. Endovascular treatment was performed, including mechanical thrombectomy using the AngioJet system and bare-metal stent placement to restore venous outflow. Follow-up imaging revealed complete thrombus resolution, hematoma regression, and sustained stent patency. Conclusions: Iliac hematomas associated with MTS may occur without definite radiological evidence of iliac vein rupture. In selected hemodynamically stable patients, an individualized endovascular strategy focused on venous outflow restoration using the AngioJet system and bare metal stents may be a feasible treatment option.